High expression of RTN4IP1 predicts adverse prognosis for patients with breast cancer

CONCLUSIONS: Overexpressed in BC tissue, RTN4IP1 predicts adverse prognosis for patients with BC, especially in infiltrating ductal carcinoma, infiltrating lobular carcinoma, Stage II, Stages III&IV and luminal A subtype.PMID:37180657 | PMC:PMC10174766 | DOI:10.21037/tcr-22-2350
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research